"Well organized and controlled processes and procedures is the real solution."
*****************************
Yes your right ....but with a double check...(valimed)..Your safer yet..
What if those nutrients were contaminated..
Take a look on Baxa's Web and their accomplishments in the area of...(total parenteral nutrition)
******************************
Interesting... History of Baxa taken from their web...
1975
Baxa Corporation is founded in Northbrook, Illinois, by Brian Baldwin and Ron Baxa as the first company to market pre-packaged inhalation drugs in pre-filled syringes. Unique Exacta-Med® Oral Liquid Dispenser provides accurate and safe delivery of oral liquid drugs.
1977
Baxa transfers sales of pre-packaged inhalation drugs to private-label customer, which later discontinues the product line. Marketing shifts to sales of empty Exacta-Med® Oral Liquid Dispensers and related products, which grow steadily.
1979
Baxa Corporation is sold to Cook Group of Indiana.
1981
Baxa relocates to Denver, Colorado to join sister Cook company, Western Research Laboratories.
1986
The company moves to its own facility in an industrial park in the south-central suburbs of Denver.
1987
Four partners, including Brian Baldwin, lead a leveraged buyout of Baxa Corporation from Cook.
1988
Brian Baldwin invents the Exacta-Med® Pharmacy Pump. The peristaltic pump, the first designed exclusively for pharmacy use, was subsequently awarded a US patent (1991).
1989
A prototype compounder for TPN (total parenteral nutrition), the MicroMacro™ Compounder, is developed from the company’s core technologies and introduced at the American Society of Health-System Pharmacists (ASHP) Mid-Year Clinical Meeting. Response is overwhelming, and prompts the creation of operating and calculation software.
Baxa expands into a 46,000 square foot facility in Englewood, Colorado to accommodate the rapidly growing business.
The first GoodNews newsletter is mailed.
Manufacturing installs a Multi-Vac custom product packaging system.
1991
First MicroMacro TPN Compounder install in the United States – Harris Methodist. Baxa acquires Apothecary Software’s TPN-PC™ and TPN-PC™ Plus software packages to automate TPN calculation, admixture verification, label preparation, and patient record management. The software is integrated with the TPN hardware to create a complete TPN compounding system.
1992
Second-generation pharmacy pump, the Repeater™ Pump, is introduced, an evolution from the unique Exacta-Med Pump design.
1993
Baxa produces its first four-color product catalog.
1994
100th MicroMacro Compounder is installed worldwide.
Outbound Telesales Center begins operation.
1995
Baxa celebrates 20 years of innovation in products for health-system pharmacies.
2,000th Repeater Pump is sold worldwide.
Exacta-Mix™ Universal Pump is introduced.
The Dual Rate Syringe Infuser (DRI) is introduced for intermittent, fixed-rate drug delivery.
Employment grows to 150 employees, worldwide.
1996
Baxa introduces a high-quality line of sterile filtration products for pharmacy admixture, in a joint-venture with Gelman Sciences.
Baxa and Abbott Laboratories enter into a long-term cooperative marketing and development plan for TPN compounding products.
Florida Hospital system implements Dual Rate Infuser system.
1997
Certification to the quality standards for ISO 9001 through Orion (ORI). The achievement is a milestone in company efforts to meet the highest level of design and production capability in the industry.
1998
Baxa introduces the MicroFuse® Infuser. This second-generation syringe infuser features enhanced durability and superior performance which allows Baxa to be the “partner of choice” for implementing small-volume syringe infusion systems.
Baxa achieves certification to EN46001, the standards for CE conformance for medical devices in the European Community.
New Exacta-Med Oral Dispenser tip design eliminates the potential for inadvertent IV administration of oral medications. Tip design will not accommodate a hypodermic needle or actuate a needleless valve.
Baxa signs co-marketing agreement with Abbott Laboratories for the MicroFuse Infuser. The agreement allows Abbott to fill a gap in their portfolio of electronic drug delivery devices.
1999
New Repeater Pump introduced for pharmacy fluid transfer. Design enhancements make the pump more reliable, convenient and durable.
2000
Baxa celebrates its 25-Year Anniversary, emphasizing its focus on service and innovation at the ASHP Mid-Year exhibit in Las Vegas, Nevada.
2001
The Exacta-Mix 600 Universal Pump is enhanced with the release of 32-Bit Direct-Entry™ Software featuring user-friendly graphics and menus.
Next-generation TPN-PC and PC Plus Software is released, incorporating user-directed changes for enhancing safety and efficiency for TPN compounding and calculation.
CALCTPN Software is released, providing a calculation foundation for health management system software packages.
Baxa intoduces new logo and tagline. Technology for Solutions reinforces the company’s position as the industry leader for fluid handling technology and creating true solutions for pharmacy needs.
2002
The Exacta-Mix 2400 Compounder is introduced, offering state-of-the-art technology for multi-source solution compounding. The EM2400 System is the market leader for pharmacy efficiency and innovation.
2003
The Rapid-Fill™ Automated Syringe Filler is introduced, the first system designed to automate sterile batch filling in the pharmacy. Automating the process of filling, capping and labeling sterile syringes minimizes the potential for contamination and reduces pharmacy overhead.
Abacus – Windows®-based order entry and calculation software for TPN compounding introduced.
Baxa signs agreement with Carmel Pharma ab to become the exclusive US distributor of the PhaSeal® products, a closed system for safe handling of hazardous drugs.
Baxa opens new 93,000 ft² headquarters facility in suburban Denver, with an 8,000 ft² ISO Class V cleanroom.
Baxa UK launches a full line of enteral syringes with connecters that directly fit feeding lines. The syringes’ distinctive purple plunger fits the color coding for enteral products in Europe.
2004
Baxa UK releases the CyTwo-Fer™ Needle for vented reconstitution of hazardous drugs.
Baxa expands it corporate headquarters, opening a new 15,000 ft² building housing the sales and marketing functions.
Today
Baxa Corporation employs more than 300 associates, worldwide, with sales approaching $100 million annually.
Product technology continues to differentiate Baxa as a leader in efficiency and safety.
Outstanding customer service and technical assistance – available 24 hours, 7 days a week – provides dedicated customer support.
Continuous product improvements result in constant product refinement and upgrades.
Sales achieving double-digit growth levels. Increased international sales penetration is expected to grow the business exponentially in the coming five years.
Market Data 
Markets 
AI
